Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
IBO	IMPACT BIOMEDICAL INC	$6.85M	-159.30%	-76.30%	-236.92%	-1,374.20%	3.45	0.22	N/A	N/A	N/A
MGTX	MEIRAGTX HOLDINGS PLC	$669.44M	-241.90%	-63.10%	-89.88%	-79.50%	5.77	1.53	27.10%	-484.90%	-447.04%
ACXP	ACURX PHARMACEUTICALS INC	$7.70M	-436.80%	-192.20%	-280.37%	362.90%	0.73	2.38	N/A	N/A	N/A
DARE	DARE BIOSCIENCE INC	$18.32M	N/A	-8.10%	65.26%	19.10%	-2.95	0.56	226.10%	-6,470.90%	-6,470.92%
LAB	STANDARD BIOTOOLS INC	$463.38M	-27.60%	-20.60%	-24.68%	-46.00%	0.28	6.12	47.00%	-78.20%	-76.11%
GRAL	GRAIL INC	$1.16B	-18.00%	-15.20%	-22.75%	-104.70%	0.17	9.23	-56.50%	-329.90%	-445.82%
SLDB	SOLID BIOSCIENCES INC	$480.45M	-71.90%	-58.50%	-55.23%	-113.40%	0.19	9.34	N/A	N/A	N/A
JUNS	JUPITER NEUROSCIENCES INC	$44.36M	N/A	-117.10%	-102.14%	257.30%	0.62	1.91	N/A	N/A	N/A
ACTU	ACTUATE THERAPEUTICS INC	$161.27M	N/A	-339.70%	541.38%	279.10%	-1.88	0.46	N/A	N/A	N/A
ALZN	ALZAMEND NEURO INC	$7.04M	-205.10%	-132.10%	-113.32%	682.60%	0.16	6.58	N/A	N/A	N/A
MASS	908 DEVICES INC	$255.13M	-13.30%	-10.20%	-11.43%	-30.90%	0.29	4.98	48.60%	-30.50%	-30.65%
SYRE	SPYRE THERAPEUTICS INC	$1.02B	-46.40%	-38.70%	-45.38%	-52.30%	0.18	6.49	N/A	N/A	N/A
HCWB	HCW BIOLOGICS INC	$6.25M	N/A	-90.10%	2,785.82%	-226.00%	-4.07	0.07	100.00%	-7,160.80%	-6,904.18%
PRME	PRIME MEDICINE INC	$477.91M	-125.10%	-66.30%	-68.79%	-97.60%	2.07	4.78	100.00%	-5,252.50%	-5,255.98%
MBX	MBX BIOSCIENCES INC	$441.54M	N/A	N/A	N/A	N/A	0.05	23.31	N/A	N/A	N/A
RAPT	RAPT THERAPEUTICS INC	$186.03M	-81.50%	-70.20%	-65.13%	-157.70%	0.06	21.11	N/A	N/A	N/A
CRBU	CARIBOU BIOSCIENCES INC	$186.25M	-71.60%	-57.00%	-85.55%	-63.50%	0.33	6.66	100.00%	-2,427.10%	-2,427.19%
MLYS	MINERALYS THERAPEUTICS INC	$936.75M	-70.40%	-65.50%	-60.84%	-126.10%	0.07	15.12	N/A	N/A	N/A
OWLT	OWLET INC	$127.41M	N/A	-34.20%	-95.86%	-197.10%	-2.46	1.19	52.20%	-20.60%	-12.15%
IKT	INHIBIKASE THERAPEUTICS INC	$127.12M	-79.00%	-70.90%	-42.63%	-281.10%	0.10	11.01	N/A	N/A	N/A
SGMT	SAGIMET BIOSCIENCES INC	$281.96M	-39.90%	-38.40%	-45.62%	-70.70%	0.06	17.55	N/A	N/A	N/A
KYMR	KYMERA THERAPEUTICS INC	$2.97B	-31.60%	-27.10%	-26.37%	-31.90%	0.16	8.32	100.00%	-616.00%	-615.36%
EKSO	EKSO BIONICS HOLDINGS INC	$8.33M	-86.60%	-41.70%	-65.70%	-83.50%	1.12	2.38	51.50%	-75.70%	-73.78%
NRXS	NEURAXIS INC	$23.37M	-652.30%	-194.90%	-149.54%	689.90%	0.67	2.82	84.80%	-242.60%	-220.34%
RMTI	ROCKWELL MEDICAL INC	$36.15M	-6.80%	-3.80%	-2.29%	-2.90%	0.73	2.89	17.50%	-2.40%	-1.09%
BDMD	BAIRD MEDICAL INVESTMENT HOLDINGS LTD	$92.18M	88.70%	24.40%	33.50%	38.10%	0.96	1.77	88.20%	33.60%	39.20%
CAI	CARIS LIFE SCIENCES INC	$10.40B	N/A	N/A	N/A	N/A	1.11	9.24	N/A	N/A	N/A
NTLA	INTELLIA THERAPEUTICS INC	$1.13B	-58.70%	-46.30%	-60.20%	-51.60%	0.26	4.90	100.00%	-1,154.10%	-1,154.10%
FULC	FULCRUM THERAPEUTICS INC	$357.00M	-31.00%	-29.00%	-33.30%	-37.50%	0.07	24.42	N/A	N/A	N/A
RPID	RAPID MICRO BIOSYSTEMS INC	$124.67M	-63.10%	-48.30%	-78.14%	-75.00%	0.39	3.67	7.50%	-145.60%	-152.69%
DMAC	DIAMEDICA THERAPEUTICS INC	$310.65M	-78.90%	-69.90%	-107.96%	-85.80%	0.16	7.55	N/A	N/A	N/A
AIMD	AINOS INC	$17.79M	-108.30%	-56.90%	-63.96%	-142.60%	1.09	2.88	82.30%	-14,182.70%	-13,453.71%
SEPN	SEPTERNA INC	$520.75M	-31.50%	-23.60%	-21.94%	-43.90%	0.10	22.09	100.00%	-12,053.00%	-12,093.80%
RNAZ	TRANSCODE THERAPEUTICS INC	$9.21M	-908.40%	-349.30%	-238.62%	2,542.80%	0.28	5.20	N/A	N/A	N/A
URGN	UROGEN PHARMA LTD	$925.84M	-97,486.60%	-49.60%	-58.90%	-60.10%	-6.33	5.65	89.70%	-150.70%	-131.84%
CGON	CG ONCOLOGY INC	$1.98B	-16.70%	-16.20%	-14.96%	-19.50%	0.03	30.97	100.00%	-15,945.20%	-15,945.17%
LYRA	LYRA THERAPEUTICS INC	$11.68M	-412.00%	-61.20%	-93.74%	-75.60%	31.41	2.78	100.00%	-5,043.60%	-5,041.17%
PDSB	PDS BIOTECHNOLOGY CORP	$55.96M	-184.60%	-79.00%	-118.39%	-336.00%	1.54	2.92	N/A	N/A	N/A
CLNN	CLENE INC	$32.34M	N/A	-93.40%	-176.24%	-113.50%	-6.09	1.36	78.90%	-8,306.00%	-7,326.57%
CNTA	CENTESSA PHARMACEUTICALS PLC	$2.37B	-56.50%	-41.80%	-46.65%	-54.70%	0.43	10.12	100.00%	-1,535.80%	-1,438.29%
HCTI	HEALTHCARE TRIANGLE INC	$5.41M	-2,325.10%	-94.70%	-50.40%	350.30%	0.37	3.07	19.50%	-51.40%	-38.29%
LTRN	LANTERN PHARMA INC	$49.35M	-99.90%	-81.60%	-153.55%	-153.70%	0.39	3.52	N/A	N/A	N/A
EDIT	EDITAS MEDICINE INC	$266.16M	-242.00%	-82.90%	-167.42%	-150.30%	9.97	2.77	100.00%	-608.90%	-622.50%
KZIA	KAZIA THERAPEUTICS LTD	$5.51M	N/A	-134.30%	-2,049.17%	330.20%	-0.85	0.21	100.00%	-1,134.80%	-1,145.67%
MGX	METAGENOMI INC	$71.31M	-38.80%	-27.80%	-37.78%	-31.50%	0.39	6.36	100.00%	-258.00%	-267.38%
TNDM	TANDEM DIABETES CARE INC	$720.29M	-104.10%	-22.10%	-31.23%	-18.00%	5.57	2.44	52.50%	-20.50%	-19.46%
NVNO	ENVVENO MEDICAL CORP	$86.61M	-57.30%	-53.50%	-68.73%	-64.60%	0.11	11.81	N/A	N/A	N/A
RAPP	RAPPORT THERAPEUTICS INC	$545.28M	-30.00%	-28.60%	-32.28%	-35.00%	0.08	22.75	N/A	N/A	N/A
OCGN	OCUGEN INC	$301.07M	-255.30%	-86.80%	-154.39%	-168.00%	16.56	1.83	100.00%	-1,197.70%	-1,156.27%
CYCC	CYCLACEL PHARMACEUTICALS INC	$13.20M	-3,641.00%	-156.00%	-253.11%	212.60%	0.22	5.60	100.00%	-59,621.40%	-55,521.43%
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$6.99M	-84.60%	-74.60%	-49.72%	-250.10%	0.08	19.49	100.00%	-29,418.80%	-29,330.82%
SERA	SERA PROGNOSTICS INC	$85.64M	-45.90%	-34.30%	-37.08%	-49.10%	0.27	1.73	-16.70%	-30,306.50%	-30,290.74%
AVIR	ATEA PHARMACEUTICALS INC	$298.67M	-31.30%	-29.30%	-33.14%	-42.80%	0.07	19.94	N/A	N/A	N/A
MRSN	MERSANA THERAPEUTICS INC	$37.03M	N/A	-57.90%	-278.51%	-11,474.40%	-2.59	1.35	100.00%	-212.90%	-202.14%
FBRX	FORTE BIOSCIENCES INC	$71.23M	-149.20%	-114.30%	-113.76%	-2,113.60%	0.24	5.22	N/A	N/A	N/A
DNA	GINKGO BIOWORKS HOLDINGS INC	$755.06M	-63.10%	-32.70%	-40.11%	-41.90%	1.00	4.88	80.00%	-198.80%	-198.98%
CDNA	CAREDX INC	$629.14M	15.20%	10.90%	11.62%	16.90%	0.36	3.30	66.90%	15.20%	11.97%
ESTA	ESTABLISHMENT LABS HOLDINGS INC	$1.10B	-210.40%	-28.60%	-25.10%	-17.00%	7.65	3.36	66.40%	-52.30%	-38.98%
EWTX	EDGEWISE THERAPEUTICS INC	$1.47B	-30.60%	-29.20%	-25.44%	-33.10%	0.04	28.87	N/A	N/A	N/A
SMLR	SEMLER SCIENTIFIC INC	$520.09M	17.20%	12.90%	9.62%	15.40%	0.36	0.60	90.80%	86.20%	108.74%
CGC	CANOPY GROWTH CORP	$275.94M	-112.80%	-52.00%	-71.78%	-51.70%	0.88	3.12	29.60%	-222.40%	-219.70%
OGI	ORGANIGRAM GLOBAL INC	$209.07M	2.30%	1.60%	-0.44%	-0.80%	0.47	2.59	33.80%	3.60%	-0.90%
VVOS	VIVOS THERAPEUTICS INC	$27.15M	-170.40%	-77.80%	-170.75%	-566.70%	1.56	0.77	58.70%	-76.80%	-76.82%
SNDX	SYNDAX PHARMACEUTICALS INC	$1.27B	-130.50%	-56.10%	-65.04%	-50.20%	2.79	4.71	96.20%	-428.50%	-401.96%
PYPD	POLYPID LTD	$53.69M	-312.80%	-120.70%	-134.93%	-203.00%	0.84	2.28	N/A	N/A	N/A
BCAX	BICARA THERAPEUTICS INC	$622.56M	-21.70%	-20.90%	-23.46%	5,046.80%	0.04	25.80	N/A	N/A	N/A
BLTE	BELITE BIO INC	$2.20B	-30.60%	-29.30%	-24.72%	-60.90%	0.04	24.31	N/A	N/A	N/A
BFRG	BULLFROG AI HOLDINGS INC	$12.90M	-196.10%	-163.00%	-316.90%	1,998.80%	0.31	3.97	19.60%	-20,966.10%	-20,849.86%
CLPT	CLEARPOINT NEURO INC	$332.03M	-94.40%	-51.60%	-39.84%	-99.60%	2.18	7.30	60.40%	-66.20%	-65.79%
CELU	CELULARITY INC	$82.86M	-271.90%	-42.80%	-65.35%	-47.40%	14.01	0.38	72.40%	-106.80%	-95.22%
ENSC	ENSYSCE BIOSCIENCES INC	$6.11M	-154.40%	-104.60%	-214.27%	-605.10%	0.74	2.10	N/A	N/A	N/A
ADTX	ADITXT INC	$2.18M	-525.20%	-122.50%	-183.74%	-181.10%	0.93	0.08	-913.90%	-67,315.70%	-53,281.46%
MTSR	METSERA INC	$3.18B	N/A	N/A	N/A	N/A	0.42	5.26	N/A	N/A	N/A
FGEN	FIBROGEN INC	$38.34M	N/A	-1.00%	2.42%	0.40%	-1.61	1.04	79.40%	2.80%	-0.74%
CRSP	CRISPR THERAPEUTICS AG	$5.35B	-25.20%	-21.50%	-24.09%	-22.70%	0.19	16.61	100.00%	-1,229.40%	-1,218.98%
IDYA	IDEAYA BIOSCIENCES INC	$2.14B	-31.40%	-29.50%	-33.65%	-36.20%	0.09	12.39	100.00%	-4,740.00%	-4,740.03%
BEAM	BEAM THERAPEUTICS INC	$1.78B	-43.20%	-31.10%	-32.75%	-42.50%	0.33	6.75	100.00%	-661.30%	-661.31%
BBLG	BONE BIOLOGICS CORP	$1.28M	-228.30%	-209.40%	-146.47%	-1,514.90%	0.09	12.59	N/A	N/A	N/A
HYPR	HYPERFINE INC	$113.94M	-84.80%	-69.40%	-105.67%	-318.20%	0.29	5.02	45.80%	-364.50%	-364.54%
MGRX	MANGOCEUTICALS INC	$17.43M	-72.80%	-66.60%	-55.20%	998.50%	0.07	0.12	57.60%	-2,187.10%	-2,187.11%
TERN	TERNS PHARMACEUTICALS INC	$592.45M	-27.40%	-26.20%	-29.75%	-57.20%	0.05	24.70	N/A	N/A	N/A
INO	INOVIO PHARMACEUTICALS INC	$86.09M	-158.30%	-93.40%	-240.23%	-230.40%	1.39	1.66	100.00%	-48,131.40%	-48,131.35%
ALLR	ALLARITY THERAPEUTICS INC	$14.78M	-151.70%	-92.70%	-124.13%	364.90%	0.59	2.66	N/A	N/A	N/A
ECOR	ELECTROCORE INC	$39.74M	-235.80%	-73.50%	-268.57%	-141.00%	12.08	1.10	85.50%	-47.80%	-47.91%
ELVN	ENLIVEN THERAPEUTICS INC	$1.17B	-29.20%	-27.90%	-20.51%	-43.10%	0.03	32.58	N/A	N/A	N/A
SLN	SILENCE THERAPEUTICS PLC	$265.66M	N/A	-41.50%	-49.42%	-85.60%	-0.76	10.06	78.50%	-290.10%	-271.70%
XAIR	BEYOND AIR INC	$12.12M	-243.20%	-115.90%	-168.22%	-138.90%	1.78	3.24	-24.60%	-880.70%	-826.24%
CNSP	CNS PHARMACEUTICALS INC	$2.74M	-385.40%	-193.20%	-142.19%	563.30%	0.25	4.94	N/A	N/A	N/A
PHAT	PHATHOM PHARMACEUTICALS INC	$730.95M	N/A	-100.30%	-123.94%	-53.20%	-1.87	3.58	86.20%	-422.40%	-333.35%
CGTX	COGNITION THERAPEUTICS INC	$121.96M	-251.20%	-130.70%	-454.35%	686.50%	1.79	1.54	N/A	N/A	N/A
SRTS	SENSUS HEALTHCARE INC	$56.55M	-1.60%	-1.40%	-0.94%	-1.50%	0.13	8.14	52.20%	-2.30%	-1.31%
ELTX	ELICIO THERAPEUTICS INC	$159.01M	N/A	-185.70%	-302.93%	-306.10%	2.16	1.83	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$116.55M	-23.10%	-22.50%	-25.11%	-35.50%	0.04	14.08	N/A	N/A	N/A
CVM	CEL SCI CORP	$24.70M	-268.40%	-110.70%	-162.85%	-105.00%	1.73	0.55	N/A	N/A	N/A
RZLT	REZOLUTE INC	$552.45M	-70.10%	-63.10%	-86.68%	-89.10%	0.15	8.43	N/A	N/A	N/A
GTBP	GT BIOPHARMA INC	$3.75M	-942.20%	-203.70%	1,191.02%	269.80%	-3.71	0.73	N/A	N/A	N/A
ELDN	ELEDON PHARMACEUTICALS INC	$155.69M	-51.60%	-27.00%	-25.16%	-32.20%	0.41	13.91	N/A	N/A	N/A
BNGO	BIONANO GENOMICS INC	$10.80M	-157.30%	-90.00%	-160.83%	-144.80%	0.63	1.70	1.70%	-294.00%	-293.84%
RNA	AVIDITY BIOSCIENCES INC	$5.55B	-27.00%	-24.60%	-26.87%	-34.70%	0.10	16.91	100.00%	-4,136.00%	-4,136.00%
SMMT	SUMMIT THERAPEUTICS INC	$19.65B	-208.60%	-181.30%	-279.62%	-375.80%	0.25	5.13	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	637	+0.16%	+4.39%	+5.40%	-64.07%	-116.18x	4.42x	-121.17%	-6.90%	-1.45%	+91.91%	Strong Buy
Diagnostics & Research	57	-0.65%	+5.82%	+10.75%	-11.64%	23.48x	3.84x	-3.66%	+7.34%	+14.22%	+6.42%	Buy
Drug Manufacturers - General	18	+1.22%	+4.73%	-2.89%	-13.96%	34.55x	5.87x	+58.71%	+10.34%	+17.79%	+52.31%	Buy
Drug Manufacturers - Specialty & Generic	77	+0.28%	+7.01%	+1.44%	-66.95%	-10.62x	2.24x	+12.23%	+4.91%	+10.43%	+33.61%	Buy
Healthcare Plans	11	+0.15%	+7.00%	-6.09%	-38.26%	13.12x	1.76x	+15.36%	+4.82%	+11.26%	+25.76%	Buy
Health Information Services	55	-0.70%	+5.29%	+3.12%	-55.42%	80.97x	4.02x	+7.39%	+4.83%	+9.55%	+21.87%	Strong Buy
Medical Care Facilities	48	-0.63%	+4.80%	+0.49%	-32.55%	15.89x	4.70x	-194.08%	+6.86%	+15.22%	+19.15%	Buy
Medical Devices	141	-0.80%	+4.06%	-1.62%	-20.79%	31.59x	3.98x	+13.01%	+8.47%	+10.00%	+30.11%	Strong Buy
Medical Distribution	10	+1.29%	+2.12%	-4.82%	+20.45%	26.65x	289.07x	-6.50%	+3.03%	+18.71%	+15.90%	Buy
Medical Instruments & Supplies	55	-1.07%	+2.00%	+0.19%	-60.20%	32.98x	3.50x	+10.58%	+8.31%	+11.13%	+23.54%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Aug 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 20 points higher than the healthcare sector average of 25. It passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 75.79% over the past year, overperforming other healthcare stocks by 124 percentage points.

Phibro Animal Health has an average 1 year price target of $30.50, a downside of -0.23% from Phibro Animal Health's current stock price of $30.57.

Phibro Animal Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Phibro Animal Health, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #2 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: D, Sentiment: B, Safety: D, Financials: A, and AI: A.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 31, which is 6 points higher than the healthcare sector average of 25. It passed 11 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock lose -5.97% over the past year, overperforming other healthcare stocks by 42 percentage points.

Embecta has an average 1 year price target of $12.00, a downside of -13.48% from Embecta's current stock price of $13.87.

Embecta stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Embecta, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #3 top healthcare stock out of 1109 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 14 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 58.19% over the past year, overperforming other healthcare stocks by 106 percentage points.

Theravance Biopharma has an average 1 year price target of $21.33, an upside of 64.86% from Theravance Biopharma's current stock price of $12.94.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 71 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Simulations Plus (NASDAQ:SLP)

Simulations Plus (NASDAQ:SLP) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2%. Simulations Plus's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Simulations Plus's dividend has shown consistent growth over the last 10 years.

Simulations Plus's dividend payout ratio of -1.9% indicates that its dividend yield might not be sustainable for the long-term.

2. Dr Reddys Laboratories (NYSE:RDY)

Dr Reddys Laboratories (NYSE:RDY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2%. Dr Reddys Laboratories's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Dr Reddys Laboratories's dividend has shown consistent growth over the last 10 years.

Dr Reddys Laboratories's dividend payout ratio of 12.2% indicates that its dividend yield is sustainable for the long-term.

3. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 14.1%, which is 12 percentage points higher than the healthcare sector average of 2%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.19% in the last day, and up 4.59% over the last week. Leap Therapeutics was the among the top losers in the healthcare sector, dropping -28.02% yesterday.

Leap Therapeutics shares are trading lower after the company reported a Q2 EPS miss.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -5.97% in the past year. It has overperformed other stocks in the healthcare sector by 42 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 5.98% in the past year. It has overperformed other stocks in the healthcare sector by 54 percentage points.

3. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 27 points higher than the healthcare sector average of 16. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 95.95% in the past year. It has overperformed other stocks in the healthcare sector by 144 percentage points.

Are healthcare stocks a good buy now?

50.6% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.32% over the next year.

5.45% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.32% of healthcare stocks are rated B (Buy), 42.3% are rated C (Hold), 26.54% are rated D (Sell), and 13.39% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 7.22x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Phibro Animal Health (NASDAQ:PAHC)

2. Embecta (NASDAQ:EMBC)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Simulations Plus (NASDAQ:SLP)

2. Dr Reddys Laboratories (NYSE:RDY)

3. Select Medical Holdings (NYSE:SEM)

1. Embecta (NASDAQ:EMBC)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Puma Biotechnology (NASDAQ:PBYI)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.